Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
anonusers Placed a 'Sell' Sentiment on UNVC1 day ago
anonusers Placed a 'Buy' Sentiment on HOME3 days ago
anonusers Placed a 'Sell' Sentiment on WBA3 days ago
russurban Placed a 'Buy' Sentiment on VXRT3 days ago
russurban Placed a 'Buy' Sentiment on OTLK3 days ago
russurban Followed OTLK3 days ago
stockarticles Placed a 'Buy' Sentiment on BB3 days ago
stockarticles Followed BB3 days ago
stockarticles Placed a 'Buy' Sentiment on SNAPMore than a week ago
Most Discussed Stocks through Posts and Reactions on SpeculatingStocks  VXRT  •  OTLK  •  PINS  •  BB  •  TWTR  •  CGC  •  ARCI  •  LULU  •  SNAP  •  IRBT

December 26, 2007 Stock Pick: Neuralstem, Inc. (CUR)

Stock Price: $3.19

Neuralstem, Inc., a biotechnology company, engages in developing and commercializing treatments based on transplanting human neural stem cells. The company uses its proprietary human neural stem cell technology to create biotherapeutic products for the treatment of central nervous system diseases and various neurodegenerative conditions, and for the regenerative repair of acute diseases.

CUR was exclusively licensed the "Spinal Multisegmental Cell and Drug Delivery System," invented by Dr. Martin Marsala at the University of California, San Diego (UCSD). The system provides a unique method for delivering spinal cord stem cells horizontally along the length of the spinal cord.

Last week, CUR entered into a clinical trial research agreement with the University of Pennsylvania aimed at treating patients with Ischemic Spastic Paraplegia, a form of spinal cord paralysis.

We believe stem cell stocks will receive much more attention in 2008 than they have in 2007 with the 2008 general election approaching. CUR has a chance to find a cure for spinal cord paralysis using stem cells.

CUR received a significant amount of attention in today's trading session, moving up over 20% on over 24 times average volume.

Untitled Document